I haven't had chance to study Amgen (disappointing?)results but I presume that failure has caused market caution towards our critter.
Guess focus of our people will be to concentrate on developing - or using existing, test methods which have potential to give early as possible indication of Cavatak performance where Amgen herpes virus critter failed to perform / deliver.